LPL Financial’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$774K Buy
366,978
+173,500
+90% +$366K ﹤0.01% 3942
2025
Q1
$236K Buy
193,478
+54,550
+39% +$66.6K ﹤0.01% 4627
2024
Q4
$179K Buy
138,928
+57,020
+70% +$73.6K ﹤0.01% 4730
2024
Q3
$225K Sell
81,908
-5,350
-6% -$14.7K ﹤0.01% 4550
2024
Q2
$197K Buy
87,258
+32,196
+58% +$72.8K ﹤0.01% 4478
2024
Q1
$132K Buy
55,062
+3,250
+6% +$7.77K ﹤0.01% 4545
2023
Q4
$86K Hold
51,812
﹤0.01% 4513
2023
Q3
$99.5K Hold
51,812
﹤0.01% 4361
2023
Q2
$74.6K Sell
51,812
-500
-1% -$720 ﹤0.01% 4324
2023
Q1
$110K Sell
52,312
-10,261
-16% -$21.5K ﹤0.01% 4161
2022
Q4
$70.7K Buy
62,573
+500
+0.8% +$565 ﹤0.01% 4199
2022
Q3
$101K Buy
62,073
+3,539
+6% +$5.76K ﹤0.01% 4073
2022
Q2
$77K Hold
58,534
﹤0.01% 4144
2022
Q1
$94K Buy
58,534
+10,900
+23% +$17.5K ﹤0.01% 3970
2021
Q4
$99K Sell
47,634
-1,900
-4% -$3.95K ﹤0.01% 4127
2021
Q3
$192K Sell
49,534
-2,500
-5% -$9.69K ﹤0.01% 3972
2021
Q2
$167K Buy
52,034
+35,750
+220% +$115K ﹤0.01% 3935
2021
Q1
$35K Sell
16,284
-1,300
-7% -$2.79K ﹤0.01% 3995
2020
Q4
$39K Sell
17,584
-1,000
-5% -$2.22K ﹤0.01% 3727
2020
Q3
$50K Sell
18,584
-9,649
-34% -$26K ﹤0.01% 3416
2020
Q2
$86K Buy
28,233
+1,722
+6% +$5.25K ﹤0.01% 3281
2020
Q1
$52K Hold
26,511
﹤0.01% 3075
2019
Q4
$76K Hold
26,511
﹤0.01% 3230
2019
Q3
$97K Sell
26,511
-3,200
-11% -$11.7K ﹤0.01% 3139
2019
Q2
$123K Sell
29,711
-2,166
-7% -$8.97K ﹤0.01% 3118
2019
Q1
$163K Buy
31,877
+3,000
+10% +$15.3K ﹤0.01% 2983
2018
Q4
$99K Sell
28,877
-916
-3% -$3.14K ﹤0.01% 2941
2018
Q3
$179K Sell
29,793
-1,000
-3% -$6.01K ﹤0.01% 3012
2018
Q2
$196K Buy
30,793
+7,200
+31% +$45.8K ﹤0.01% 2965
2018
Q1
$112K Buy
+23,593
New +$112K ﹤0.01% 3043